Affiliations 

  • 1 Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu
  • 2 School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK
  • 3 Tuberculosis Division, United States Agency for International Development, Washington, DC, USA
  • 4 Department of Global Health and Population, Harvard University, Cambridge, MA, USA
  • 5 Foundation for Innovative New Diagnostics, Geneva, Switzerland
  • 6 Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA
  • 7 Bill & Melinda Gates Foundation, Seattle, WA, USA
  • 8 The Aurum Institute, Johannesburg, South Africa
  • 9 Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
  • 10 Stop TB Partnership, Geneva, Switzerland
  • 11 Department of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA
  • 12 The Wellcome Trust, London, UK
  • 13 National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA
  • 14 Volunteer Health Services, Addis Ababa, Ethiopia
  • 15 Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France
  • 16 Treatment Action Group, New York, NY, USA
  • 17 Global TB Caucus, Houses of Parliament, London, UK
  • 18 Department of Medicine, University of California San Francisco, San Francisco, CA, USA
  • 19 Department of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan
  • 20 Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
  • 21 Interactive Research & Development, Karachi, Pakistan
  • 22 Global Health Bureau, United States Agency for International Development, Washington, DC, USA
  • 23 Resource Group for Education and Advocacy for Community Health, Chennai, India
  • 24 South African National Department of Health, Pretoria, South Africa
  • 25 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada
  • 26 University of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland
  • 27 Academy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan
  • 28 Global Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA
  • 29 WHO, Geneva, Switzerland
  • 30 Department of Infectious Diseases, Mayo Clinic, Rochester, MI, USA
  • 31 Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands
  • 32 The Economic Times, Mumbai, India
  • 33 KNCV Tuberculosis Foundation, The Haag, Netherlands
  • 34 Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA
  • 35 Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
  • 36 Institutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova
  • 37 Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
  • 38 Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
  • 39 Center for Health Policies and Studies, Chisinau, Moldova
  • 40 McGill International TB Center, McGill University, Montreal, QC, Canada
  • 41 Bill & Melinda Gates Foundation, New Delhi, India
  • 42 T H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Mānoa, HI, USA
  • 43 Division of Infectious Diseases & HIV Medicine, Case Western Reserve University, Cleveland, OH, USA
  • 44 Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA
  • 45 Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
  • 46 Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia
  • 47 Revised National TB Control Program, New Delhi, India
  • 48 National Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya
  • 49 General TB control, New Delhi, India
  • 50 WHO, Nairobi, Kenya
  • 51 Office of the Secretary-General's Special Envoy on Tuberculosis, United Nations, Geneva, Switzerland
  • 52 International Institute of Social Studies, Erasmus University Rotterdam, The Hague, Netherland
  • 53 Department of Global Health and Population, Harvard University, Cambridge, MA, USA; Global Health Centre, The Graduate Institute Geneva, Geneva, Switzerland
  • 54 Linksbridge, Seattle, WA, USA
  • 55 Central Tuberculosis Division, WHO, New Delhi, India
  • 56 Ministry of Health and Family Welfare, New Delhi, India
  • 57 International Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia
  • 58 Department of Medicine, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa
  • 59 Seattle, WA, USA
  • 60 National TB Program, WHO, Chisinau, Moldova
  • 61 Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
Lancet, 2019 Mar 30;393(10178):1331-1384.
PMID: 30904263 DOI: 10.1016/S0140-6736(19)30024-8

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.